Annual Net Income
-$9.64 M
+$968.00 K+9.13%
01 December 2023
Summary:
NovaBay Pharmaceuticals annual net profit is currently -$9.64 million, with the most recent change of +$968.00 thousand (+9.13%) on 01 December 2023. During the last 3 years, it has fallen by -$3.82 million (-65.52%). NBY annual net income is now -457.43% below its all-time high of $2.70 million, reached on 31 December 2009.NBY Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$1.21 M
+$373.00 K+23.53%
01 September 2024
Summary:
NovaBay Pharmaceuticals quarterly net profit is currently -$1.21 million, with the most recent change of +$373.00 thousand (+23.53%) on 01 September 2024. Over the past year, it has increased by +$2.90 million (+70.50%). NBY quarterly net income is now -135.49% below its all-time high of $3.42 million, reached on 31 December 2009.NBY Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$10.12 M
+$545.00 K+5.11%
01 September 2024
Summary:
NovaBay Pharmaceuticals TTM net profit is currently -$10.12 million, with the most recent change of +$545.00 thousand (+5.11%) on 01 September 2024. Over the past year, it has dropped by -$479.00 thousand (-4.97%). NBY TTM net income is now -475.19% below its all-time high of $2.70 million, reached on 31 December 2009.NBY TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBY Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +70.5% | -5.0% |
| 3 y3 years | -65.5% | -667.1% | -73.8% |
| 5 y5 years | +0.2% | +54.9% | -4.8% |
NBY Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -65.5% | +9.1% | -991.9% | +85.2% | -295.3% | +26.3% |
| 5 y | 5 years | -65.5% | +12.7% | -991.9% | +85.2% | -295.3% | +26.3% |
| alltime | all time | -457.4% | +49.2% | -135.5% | +85.2% | -475.2% | +47.9% |
NovaBay Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.21 M(-23.5%) | -$10.12 M(-5.1%) |
| June 2024 | - | -$1.58 M(-50.7%) | -$10.66 M(-4.1%) |
| Mar 2024 | - | -$3.21 M(-21.8%) | -$11.12 M(+15.3%) |
| Dec 2023 | -$9.64 M(-9.1%) | -$4.11 M(+133.8%) | -$9.64 M(-29.8%) |
| Sept 2023 | - | -$1.76 M(-13.7%) | -$13.74 M(+13.4%) |
| June 2023 | - | -$2.04 M(+17.1%) | -$12.12 M(-1.0%) |
| Mar 2023 | - | -$1.74 M(-78.8%) | -$12.24 M(+15.3%) |
| Dec 2022 | -$10.61 M(+82.1%) | -$8.21 M(+5933.8%) | -$10.61 M(+314.4%) |
| Sept 2022 | - | -$136.00 K(-93.7%) | -$2.56 M(-45.7%) |
| June 2022 | - | -$2.15 M(+1841.4%) | -$4.71 M(+6.7%) |
| Mar 2022 | - | -$111.00 K(-29.7%) | -$4.42 M(-24.2%) |
| Dec 2021 | -$5.82 M(-47.2%) | -$158.00 K(-93.1%) | -$5.82 M(-21.5%) |
| Sept 2021 | - | -$2.29 M(+23.1%) | -$7.42 M(-11.2%) |
| June 2021 | - | -$1.86 M(+22.5%) | -$8.35 M(-23.9%) |
| Mar 2021 | - | -$1.52 M(-13.5%) | -$10.97 M(-0.6%) |
| Dec 2020 | -$11.04 M(+14.3%) | -$1.75 M(-45.5%) | -$11.04 M(-7.8%) |
| Sept 2020 | - | -$3.22 M(-28.1%) | -$11.97 M(+32.5%) |
| June 2020 | - | -$4.48 M(+183.3%) | -$9.03 M(+28.1%) |
| Mar 2020 | - | -$1.58 M(-41.1%) | -$7.05 M(-27.0%) |
| Dec 2019 | -$9.66 M(+47.6%) | -$2.69 M(+852.5%) | -$9.66 M(+17.2%) |
| Sept 2019 | - | -$282.00 K(-88.7%) | -$8.24 M(-13.2%) |
| June 2019 | - | -$2.50 M(-40.3%) | -$9.50 M(+10.6%) |
| Mar 2019 | - | -$4.19 M(+230.4%) | -$8.58 M(+31.2%) |
| Dec 2018 | -$6.54 M(-11.6%) | -$1.27 M(-17.6%) | -$6.54 M(+46.0%) |
| Sept 2018 | - | -$1.54 M(-3.2%) | -$4.48 M(-16.9%) |
| June 2018 | - | -$1.59 M(-26.1%) | -$5.39 M(-2.7%) |
| Mar 2018 | - | -$2.15 M(-371.1%) | -$5.54 M(-25.1%) |
| Dec 2017 | -$7.40 M(-43.7%) | $793.00 K(-132.4%) | -$7.40 M(-24.8%) |
| Sept 2017 | - | -$2.45 M(+40.8%) | -$9.84 M(-11.6%) |
| June 2017 | - | -$1.74 M(-56.7%) | -$11.13 M(-7.9%) |
| Mar 2017 | - | -$4.01 M(+143.4%) | -$12.09 M(-8.1%) |
| Dec 2016 | -$13.15 M(-30.7%) | -$1.65 M(-55.9%) | -$13.15 M(-16.3%) |
| Sept 2016 | - | -$3.74 M(+38.9%) | -$15.71 M(-8.7%) |
| June 2016 | - | -$2.69 M(-47.0%) | -$17.21 M(-11.3%) |
| Mar 2016 | - | -$5.08 M(+20.8%) | -$19.41 M(+2.3%) |
| Dec 2015 | -$18.97 M(+24.9%) | -$4.20 M(-19.8%) | -$18.97 M(-1.4%) |
| Sept 2015 | - | -$5.24 M(+7.3%) | -$19.24 M(+5.6%) |
| June 2015 | - | -$4.89 M(+5.3%) | -$18.21 M(+12.0%) |
| Mar 2015 | - | -$4.64 M(+3.8%) | -$16.27 M(+7.1%) |
| Dec 2014 | -$15.19 M | -$4.47 M(+5.9%) | -$15.19 M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | -$4.22 M(+43.4%) | -$14.86 M(+2.6%) |
| June 2014 | - | -$2.94 M(-17.5%) | -$14.49 M(-7.1%) |
| Mar 2014 | - | -$3.56 M(-13.8%) | -$15.60 M(-2.8%) |
| Dec 2013 | -$16.04 M(+128.3%) | -$4.14 M(+7.5%) | -$16.04 M(+12.5%) |
| Sept 2013 | - | -$3.85 M(-4.9%) | -$14.26 M(+38.0%) |
| June 2013 | - | -$4.05 M(+1.0%) | -$10.33 M(+21.4%) |
| Mar 2013 | - | -$4.01 M(+70.6%) | -$8.51 M(+21.0%) |
| Dec 2012 | -$7.03 M(+38.2%) | -$2.35 M(-3037.5%) | -$7.03 M(-15.4%) |
| Sept 2012 | - | $80.00 K(-103.6%) | -$8.30 M(+0.3%) |
| June 2012 | - | -$2.23 M(-12.1%) | -$8.28 M(+47.1%) |
| Mar 2012 | - | -$2.53 M(-30.2%) | -$5.63 M(+10.7%) |
| Dec 2011 | -$5.08 M(+18.0%) | -$3.63 M(-3522.6%) | -$5.08 M(+292.4%) |
| Sept 2011 | - | $106.00 K(-75.1%) | -$1.30 M(-57.4%) |
| June 2011 | - | $425.00 K(-121.4%) | -$3.04 M(-34.8%) |
| Mar 2011 | - | -$1.99 M(-1334.8%) | -$4.67 M(+8.3%) |
| Dec 2010 | -$4.31 M(-259.7%) | $161.00 K(-109.8%) | -$4.31 M(+308.7%) |
| Sept 2010 | - | -$1.64 M(+37.1%) | -$1.05 M(-321.0%) |
| June 2010 | - | -$1.20 M(-26.5%) | $477.00 K(-65.6%) |
| Mar 2010 | - | -$1.63 M(-147.7%) | $1.39 M(-48.6%) |
| Dec 2009 | $2.70 M(-133.2%) | $3.42 M(-3176.6%) | $2.70 M(-219.7%) |
| Sept 2009 | - | -$111.00 K(-61.6%) | -$2.25 M(-37.9%) |
| June 2009 | - | -$289.00 K(-9.1%) | -$3.63 M(-36.9%) |
| Mar 2009 | - | -$318.00 K(-79.3%) | -$5.75 M(-29.1%) |
| Dec 2008 | -$8.11 M(+50.3%) | -$1.54 M(+3.2%) | -$8.11 M(+1.8%) |
| Sept 2008 | - | -$1.49 M(-38.2%) | -$7.97 M(-0.8%) |
| June 2008 | - | -$2.41 M(-10.0%) | -$8.04 M(+11.9%) |
| Mar 2008 | - | -$2.68 M(+92.1%) | -$7.18 M(+33.1%) |
| Dec 2007 | -$5.40 M(+2.2%) | -$1.39 M(-10.4%) | -$5.40 M(+3.7%) |
| Sept 2007 | - | -$1.56 M(-0.1%) | -$5.21 M(+3.6%) |
| June 2007 | - | -$1.56 M(+74.4%) | -$5.03 M(+1.3%) |
| Mar 2007 | - | -$893.00 K(-25.6%) | -$4.96 M(-6.1%) |
| Dec 2006 | -$5.29 M(+52.6%) | -$1.20 M(-12.6%) | -$5.29 M(+6.8%) |
| Sept 2006 | - | -$1.37 M(-8.0%) | -$4.95 M(+11.4%) |
| June 2006 | - | -$1.49 M(+22.6%) | -$4.44 M(+16.4%) |
| Mar 2006 | - | -$1.22 M(+40.6%) | -$3.82 M(+10.2%) |
| Dec 2005 | -$3.46 M(+23.5%) | -$866.00 K(0.0%) | -$3.46 M(+33.3%) |
| Sept 2005 | - | -$866.00 K(0.0%) | -$2.60 M(+50.0%) |
| June 2005 | - | -$866.00 K(0.0%) | -$1.73 M(+100.0%) |
| Mar 2005 | - | -$866.00 K | -$866.00 K |
| Dec 2004 | -$2.80 M(+187.0%) | - | - |
| Dec 2003 | -$977.00 K | - | - |
FAQ
- What is NovaBay Pharmaceuticals annual net profit?
- What is the all time high annual net income for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly net income year-on-year change?
- What is NovaBay Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals TTM net income year-on-year change?
What is NovaBay Pharmaceuticals annual net profit?
The current annual net income of NBY is -$9.64 M
What is the all time high annual net income for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual net profit is $2.70 M
What is NovaBay Pharmaceuticals quarterly net profit?
The current quarterly net income of NBY is -$1.21 M
What is the all time high quarterly net income for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly net profit is $3.42 M
What is NovaBay Pharmaceuticals quarterly net income year-on-year change?
Over the past year, NBY quarterly net profit has changed by +$2.90 M (+70.50%)
What is NovaBay Pharmaceuticals TTM net profit?
The current TTM net income of NBY is -$10.12 M
What is the all time high TTM net income for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high TTM net profit is $2.70 M
What is NovaBay Pharmaceuticals TTM net income year-on-year change?
Over the past year, NBY TTM net profit has changed by -$479.00 K (-4.97%)